Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.13M | -2.81M | -4.50M | -4.73M | -4.98M |
| Total Depreciation and Amortization | 687.20K | 631.20K | 571.00K | 482.30K | 395.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.70K | 14.90K | -169.50K | 647.10K | 1.48M |
| Change in Net Operating Assets | -2.04M | -392.90K | 1.29M | 1.29M | 1.29M |
| Cash from Operations | -2.29M | -2.55M | -2.81M | -2.31M | -1.82M |
| Capital Expenditure | -39.50K | -38.20K | -36.80K | -22.30K | -7.80K |
| Sale of Property, Plant, and Equipment | -- | 10.40K | 20.90K | 20.90K | 20.90K |
| Cash Acquisitions | -1.50M | -1.28M | -1.06M | -466.40K | 125.50K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.49M | 1.39M | 1.29M | 228.20K | -841.90K |
| Cash from Investing | -44.60K | 84.00K | 217.00K | -239.70K | -703.50K |
| Total Debt Issued | 861.00K | 580.50K | 300.00K | 300.00K | 300.00K |
| Total Debt Repaid | -1.04M | -804.00K | -567.00K | -652.50K | -738.00K |
| Issuance of Common Stock | 4.66M | 3.91M | 3.16M | 2.71M | 2.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -564.00K | -479.50K | -395.00K | -297.00K | -199.00K |
| Cash from Financing | 2.58M | 2.12M | 1.65M | 1.36M | 1.09M |
| Foreign Exchange rate Adjustments | -6.60K | -5.90K | -5.20K | 8.50K | 22.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 242.20K | -356.10K | -953.40K | -1.18M | -1.40M |